The profiling of 11 NB TIC lines from 6 NB patients using next-generation RNA sequencing and/or human exon arrays showed frequent mis-expression in the genes of the BRCA1 signaling pathway. The Ingenuity Pathways Analysis tool was applied to predict AURKB drug as a potential novel target for NB. Here, AURKB is linked to neuroblastoma.